Searchable abstracts of presentations at key conferences in endocrinology

ea0099rc5.1 | Rapid Communications 5: Pituitary and Neuroendocrinology | Part I | ECE2024

Clinical use of 18F-fluoro-ethyl-tyrosine PET co-registered with MRI for diagnostic dilemmas in prolactinoma

van Trigt Victoria , Bakker Leontine , Lu Ling , Pelsma Iris , Verstegen Marco , van Furth Wouter , Arias-Bouda Lenka Pereira , Biermasz Nienke

Purpose : To assess the utility of (18F)fluoroethyl-L-tyrosine PET co-registered with magnetic resonance imaging (FET-PET/MRICR) in patients with difficult-to-localize prolactinoma to inform clinical decision making and treatment planning.Methods: Retrospective cohort study of 17 consecutive patients with difficult-to-localize prolactinoma undergoing FET-PET/MRICR between October 2020 and Amgust 2022 for either (1) additional inform...